3. What is Pharmacovigilance?
The science and activities
relating to the detection,
assessment, understanding
and prevention of adverse
effects or any other drug-
related problem.
4. ï Insufficient evidence of safety from clinical trials
1959-61 thalidomide disaster ( 4000-100000 case)
Why do we need pharmacovigilance?
5. ContâdâŠ
ï Medicines are supposed to save lives
Dying from a disease is sometimes unavoidable; dying from a
medicine is unacceptable. Lepakhin V. Geneva 2005
ï Promoting rational use of medicines and adherence.
7. ContâdâŠ
ï ADRs are expensive !!
Cost of ADRs in the US:
Cost of drug related morbidity and mortality exceeded
$177.4 billion in 2000 (Ernst FR & Grizzle AJ, 2001: J American
Pharm. Assoc)
ADR related cost to the country exceeds the cost of the
medications themselves.
8. ContâdâŠ
ï Ethics:
To know of something that is harmful to another
person who does not know, and not telling, is unethical.
ï No medicine is risk free, vigilant
assessment of the risks and benefits
of medicine promote safety.
9. Aims of pharmacovigilance
ïTo improve patient care and safety
ïTo improve public health and safety
ïTo contribute to the assessment of benefit, harm,
effectiveness and risk of medicine.
10. Adverse drug reactions[ADRs] monitoring
ï Monitoring centre:
- WHO collaborating centre for international drug
monitoring , Uppsala Monitoring Centre, Sweden.
- Established in1968.
ïIn Bangladesh:
- Directorate General of Drug Administration.
11. ContâdâŠ
ï Monitoring of ADRs:
- Clinical trial monitoring
- Prescription event monitoring
- Yellow card system
12. ADRs reporting:
ï Who to report:
- All health care professionals.
ï What to report:
- Any suspected ADRs.
13. ContâdâŠ
ï How to report:
- ADRs form
- Assessment tool: Naranjo scale
ï Where to report:
- National body